GLENMARK PHARMACEUTICALS
Alış
Güncellendi

Anchored VWAP Study of Glenmark Pharma

218
[May 22, 2020, Friday EOD analysis]

Anchored VWAP Analysis self explanatory in Chart. Additional Pointers:

- Range Breakout in place
- Breakout accompanied with Expanding volume signaling the Range was an Accumulation Zone
- Stock is also above 5 day EMA , 20 day EMA, 50 day EMA, 65 day EMA (ALL are Sloping upwards and above each other respectively)
- ADX is above 25 on daily chart (trending)

Concern:
-200 day EMA is Sloping down but stock price is above it
- 100 day EMA is above 50 & 65 day EMA but sloping up

Key Target Levels:
1) 370-75
2) 385
3) 399
Not
correction: It is 200 day MA & not 200 day EMA which I was referring to

Talking about the 200 day EMA:
- the stock price is below it and facing stiff resistance at it since the range was created
- 200 day EMA is also downward sloping
İşlem elle kapatılmış
WILL not be Updating this Idea further...

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.